Publications Office of the EU
Georgia-Tbilisi: Vaccines - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Georgia-Tbilisi: Vaccines

Overview
  • Awarded
    05/06/2021
  • Today
    24/04/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia
Place of performance
NUTS code: Georgia
Location of buyer
NUTS code: Georgia
Business sector (Main CPV)
33651600 Vaccines
Total estimated contract value (excluding VAT)
1.00
Total final contract value (excluding VAT)
1.00 USD
Procedure details
Tender reference number
EIB-GtP/INCO 20160405 26
Description

Purchase Contracts for COVID- 19 vaccines (Vero Cell) inactivated

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
Georgia
CPV code

33651600 - Vaccines

Award method
Lowest price
Estimated value
1.00
Final contracted value
1.00 USD
Award of contract
Official name: Sinovac Life Science Co., LTD
Postal address: No 21 Tianfu Street, Daxing Biomedicine Industrial Base, Zhongguancum Science Park, Daxing District
Town: Beijing
Postal code:
Country: CHN
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.